Purchase Order 75N91023P00707
- Not listed
- This is a $14,000 firm fixed-price purchase order contract awarded to Atlasxomics Inc. by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq kits to support the agency's genomics and cancer research. Atlasxomics is a biotechnology company that specializes in spatial multi-omics technologies, including its proprietary Deterministic Barcoding in...
- This $22,000 firm fixed-price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) kits to support NIAMS'...
- This is a $95,474.20 firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. to provide single cell RNA sequencing and ATAC sequencing kits. The contract has an ultimate completion date of August 24, 2024. As the prime contractor, 10X Genomics, a life sciences technology company, will supply specialized genomic analysis products and related services to support biomedical research efforts....
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to 10X Genomics, Inc., a small business manufacturer of life sciences technology products. The $204,478.68 firm fixed price purchase order is for the supply of 10X Genomics' Multiome and single-cell ATAC kits, including dual index kits, single index kits, gene expression reagent bundles, and related microfluidic chips. This...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' Office of Logistics and Acquisition Operations to 10X Genomics, Inc., doing business as 10X Genomics. The $49,121.00 contract provides specialized genomics analysis products and services to support biomedical research efforts, primarily for the NIH and its various institutes and centers. The products include kits for single-cell RNA sequencing, single-cell ATAC sequencing, single-cell...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,102.75 firm fixed price contract to 10X Genomics, Inc. for single cell RNA sequencing on provided RNA samples. 10X Genomics will perform the requested 5' prime single cell RNA sequencing services at their Pleasanton, California facility between February 2nd and 28th, 2023. The National Cancer Institute seeks to advance cancer research and this contract will provide genomic analysis...
- This is a firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to 10X Genomics, Inc., a for-profit manufacturer, to provide specialized genomic analysis products and services, including single-cell RNA sequencing, ATAC sequencing, multi-omics, and spatial transcriptomics platforms, instruments, and associated support. The...
- This is a $24,992.79 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis products. The contract is for the delivery of 10X Expression Kits, which support single-cell RNA sequencing, single-cell ATAC sequencing, multi-omics analysis, and spatial transcriptomics research. This contract is not set aside and...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute, which is part of the National Institutes of Health (NIH), a civilian federal agency, to 10X Genomics, Inc., a manufacturer of genomic analysis platforms, reagents, and instruments. The contract is valued at $12,000.00 and has an ultimate completion date of September 19, 2026. The contract does not have a set-aside designation. 10X Genomics supplies specialized scientific equipment, consumables, and research tools...
- The National Cancer Institute (NCI) awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $15,150.50 to 10X Genomics, Inc. on August 28, 2022, with an ultimate completion date of September 27, 2022. The contract, with no set-aside designation, calls for single-cell isolation and sequencing reagents and equipment from tumor and metastatic sites to support cancer research conducted by Jae Young So and Abdul Ahad. The work will be performed at 10X Genomics' facility in...
This is a $52,500.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for ATAC sequencing analysis of 15 samples, which supports NCI's research into chromatin accessibility and gene regulation in cancer. The original contract opportunity was a sole-source procurement for Atlasxomics' proprietary spatial ATAC-seq technology, which the agency determined could provide the most robust epigenomic profiles within a spatial context. The contract does not have a set-aside designation, and no major subcontractors were indicated. Atlasxomics has received both federal contracts and grants from NIH agencies, including the National Human Genome Research Institute and NCI, to further develop and commercialize its innovative spatial biology platforms.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source -Spatial ATAC Sequencing for 15 Liver Cancer Samples | 75N91023Q00129 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Pre-Solicitation 1/1 | 7/13/23, 3:53 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.5k | 8/17/23 |